Responses
ePoster Viewing: Trials-in-Progress
AS04. Endometrial/Uterine corpus cancers
TP009/#1495 A phase 2, open-label, single-arm, prospective, multi-center study of nab-sirolimus plus letrozole in advanced or recurrent endometrioid endometrial cancer
Compose a Response to This Article
Other responses
No responses have been published for this article.